A narrative review of risk factors and interventions for cancer-related cognitive impairment
文献类型：期刊论文
| 作者 | Bai, Lu1,2; Yu, Enyan1,2 |
| 刊名 | ANNALS OF TRANSLATIONAL MEDICINE
 |
| 出版日期 | 2021 |
| 卷号 | 9 |
| ISSN号 | 2305-5839 |
| 关键词 | Cancer cognitive impairment risk factors treatment |
| DOI | 10.21037/atm-20-6443 |
| 通讯作者 | Yu, Enyan(yuenyan@aliyun.com) |
| 英文摘要 | Cancer-related cognitive impairment (CRCI) refers to a series of cognitive impairment symptoms associated with alternations in brain structure and function, caused by a non-central nervous system malignant tumor and its related treatment. CRCI may present as memory loss, impaired concentration, difficulty in multitasking and word retrieval, and reduced comprehension speed. CRCI has become one of the prevalent factors that compromise the quality of life for cancer survivors. Different treatments, including surgery, chemotherapy, radiotherapy, endocrine therapy, and targeted drugs, may contribute to CRCI. Meanwhile, patients' factors, including emotional challenges and genetic makeup, also contribute to the development of CRCI. The condition can be treated with using stimulants methylphenidate and modafinil, metabolites of nicotine: cotinine, antidepressants of fluoxetine and fluvoxamine, dementia drug of donepezil, and antioxidants ZnSO4, n-acetyl cysteine, propofol, and Chinese herbal of silver leaf medicine. Psychotherapies, including meditation and relaxation, cognitive rehabilitation training, along with physical therapies, including aerobic exercise, resistance training, balance training, yoga, qigong, tai chi electroencephalogram biofeedback, and acupuncture, are also beneficial in alleviating cancer-related cognitive impairment symptoms. In recent years, researchers have focused on factors related to the condition and on the available interventions. However, most research was conducted independently, and no review has yet summarized the latest findings. This review details and discusses the status of related factors and potential treatments for CRCI. We also supply specific recommendations to facilitate future research and integration in this field. |
| WOS关键词 | QUALITY-OF-LIFE ; ACUTE LYMPHOCYTIC-LEUKEMIA ; BREAST-CANCER ; ADJUVANT CHEMOTHERAPY ; LONGITUDINAL ASSESSMENT ; EXECUTIVE FUNCTION ; NEUROPSYCHOLOGICAL PERFORMANCE ; PHYSICAL-ACTIVITY ; APOLIPOPROTEIN-E ; HORMONE-THERAPY |
| 资助项目 | National Natural Science Foundation of China[81771158] |
| WOS研究方向 | Oncology ; Research & Experimental Medicine |
| 语种 | 英语 |
| 出版者 | AME PUBL CO |
| WOS记录号 | WOS:000614551200012 |
| 资助机构 | National Natural Science Foundation of China |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/120616]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 通讯作者 | Yu, Enyan |
| 作者单位 | 1.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Hangzhou, Peoples R China 2.Chinese Acad Sci, Inst Canc & Basic Med, Beijing, Peoples R China |
| 推荐引用方式 GB/T 7714 | Bai, Lu,Yu, Enyan. A narrative review of risk factors and interventions for cancer-related cognitive impairment[J]. ANNALS OF TRANSLATIONAL MEDICINE,2021,9. |
| APA | Bai, Lu,&Yu, Enyan.(2021).A narrative review of risk factors and interventions for cancer-related cognitive impairment.ANNALS OF TRANSLATIONAL MEDICINE,9. |
| MLA | Bai, Lu,et al."A narrative review of risk factors and interventions for cancer-related cognitive impairment".ANNALS OF TRANSLATIONAL MEDICINE 9(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。